Home › Funds › BlackRock Inc › BCLI
BlackRock Inc position in BCLI
BRAINSTORM CELL THERAPEUTICS
Latest position (Q2 2025)25.17K sh
Reported value held$28.19K
Portfolio Weight0.00%
First reportedQ3 2024
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 377.61K | $86.96K | New |
| Q4 2024 | 25.17K | $57.14K | Reduce |
| Q1 2025 | 25.17K | $31.72K | Hold |
| Q2 2025 | 25.17K | $28.19K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.